These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4358600)

  • 1. Improved purification and further characterization of Clostridium perfringens type A enterotoxin.
    Hauschild AH; Hilsheimer R; Martin WG
    Can J Microbiol; 1973 Nov; 19(11):1379-82. PubMed ID: 4358600
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characteristics of the enterotoxin of Clostridium perfringens type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1971 Nov; 17(11):1425-33. PubMed ID: 4333491
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical modification and characterization of enterotoxin from clostridium perfringens type A.
    Granum PE; Skjelkvåle R
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):89-94. PubMed ID: 190854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of an enterotoxin from a coatless spore mutant of Clostridium perfringens type A.
    Lindsay JA; Sleigh RW; Ghitgas C; Davenport JB
    Eur J Biochem; 1985 Jun; 149(2):287-93. PubMed ID: 2859989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Clostridium perfringens type A enterotoxin by electroimmunodiffusion.
    Duncan CL; Somers EB
    Appl Microbiol; 1972 Nov; 24(5):801-4. PubMed ID: 4344960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and some chemical and physical properties of staphylococcal enterotoxin A.
    Schantz EJ; Roessler WG; Woodburn MJ; Lynch JM; Jacoby HM; Silverman SJ; Gorman JC; Spero L
    Biochemistry; 1972 Feb; 11(3):360-6. PubMed ID: 4621755
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and biochemical properties of Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1972 Nov; 6(5):662-73. PubMed ID: 4344364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved method for purification of enterotoxin from Clostridium perfringens type A.
    Granum PE; Whitaker JR
    Appl Environ Microbiol; 1980 Jun; 39(6):1120-2. PubMed ID: 6250473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of two Clostridium perfringens enterotoxin-like proteins and their effects on membrane permeability in primary cultures of adult rat hepatocytes.
    Dasgupta BR; Pariza MW
    Infect Immun; 1982 Nov; 38(2):592-7. PubMed ID: 6292107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. II. Purification of enterotoxin A.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):159-64. PubMed ID: 806302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anomalous aggregation of Clostridium perfringens enterotoxin under dissociating conditions.
    Enders GL; Duncan CL
    Can J Microbiol; 1976 Sep; 22(9):1410-4. PubMed ID: 184907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and function of a Clostridium perfringens enterotoxin fragment.
    Horiguchi Y; Akai T; Sakaguchi G
    Infect Immun; 1987 Dec; 55(12):2912-5. PubMed ID: 2890582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a parasporal inclusion body from sporulating, enterotoxin-positive Clostridium perfringens type A.
    Löffler A; Labbé R
    J Bacteriol; 1986 Feb; 165(2):542-8. PubMed ID: 2867991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of a protein fraction that chromatographically precedes the Clostridium perfringens toxin spore].
    Mayorga Corredor I; Torres-Anjel MJ; Figueroa J
    Rev Latinoam Microbiol; 1978; 20(1):13-24. PubMed ID: 220690
    [No Abstract]   [Full Text] [Related]  

  • 17. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. I. Purification of enterotoxin C2.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):148-58. PubMed ID: 237564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enterotoxin produced by Clostridium perfringens type D. Purification by affinity chromatography.
    Uemura T; Skjelkvåle R
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):414-20. PubMed ID: 187011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of enterotoxin purified from Clostridium perfringens type C.
    Skjelkvålé R; Duncan CL
    Infect Immun; 1975 May; 11(5):1061-8. PubMed ID: 164411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparative polyacrylamide gel electrophoresis purification of Clostridium perfringens enterotoxin.
    Enders GL; Duncan CL
    Infect Immun; 1977 Aug; 17(2):425-9. PubMed ID: 197021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.